Requires investigating of critical prescription drug pricing; provides for civil penalties and private actions for certain critical prescription drug pricing.
STATE OF NEW YORK
________________________________________________________________________
396
2025-2026 Regular Sessions
IN SENATE(Prefiled)
January 8, 2025
___________
Introduced by Sen. MYRIE -- read twice and ordered printed, and when
printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to investigating critical
prescription drug pricing
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. The insurance law is amended by adding a new section 346 to
2 read as follows:
3 § 346. Investigation by the superintendent with respect to critical
4 prescription drugs. (a) Whenever it shall appear to the superintendent,
5 either upon complaint or otherwise, that in the advertisement, purchase
6 or sale within this state of any critical prescription drug, that the
7 price of that critical prescription drug has increased over the course
8 of any twelve months by more than the increase of the cost of living
9 index for the list price of that critical prescription drug, or if it is
10 suspected that any person, partnership, corporation, company, trust or
11 association, or any agent or employee thereof has sold or offered for
12 sale or is attempting to sell or is offering for sale any critical
13 prescription drug for which the price of that drug has increased over
14 the course of any twelve months by more than the increase of the cost of
15 living index for the list price of that drug, or if the superintendent
16 believes it is to the public interest to investigate, the superintendent
17 shall require such person, partnership, corporation, company, trust or
18 association, or any agent or employee thereof, to file with the depart-
19 ment a statement in writing under oath or otherwise as to all the facts
20 and circumstances concerning the price increase and for that purpose may
21 prescribe forms upon which such statements shall be made.
22 (b) In addition to any other power granted by law, the superintendent,
23 their deputy or other officer designated by the superintendent is
24 empowered to subpoena witnesses, compel their attendance, examine them
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD01571-01-5
S. 396 2
1 under oath and require the production of any books or papers which they
2 deem relevant or material to the inquiry. Such power of subpoena and
3 examination shall not abate or terminate by reason of any action or
4 proceeding brought by the attorney general.
5 (c) No person shall be excused from attending such inquiry in
6 pursuance to the mandates of a subpoena, or from producing a paper or
7 book, or from being examined or required to answer a question on the
8 ground of failure of tender or payment of a witness fee and/or mileage,
9 unless at the time of such appearance or production, as the case may be,
10 such witness makes demand for such payment as a condition precedent to
11 the offering of testimony or production required by the subpoena and
12 unless such payment is not thereupon made. The provisions for payment of
13 witness fee and/or mileage shall not apply to any officer, director or
14 person in the employ of any person, partnership, corporation, company,
15 trust or association whose conduct or practices are being investigated.
16 (d) If a person subpoenaed to attend such inquiry fails to obey the
17 command of a subpoena without reasonable cause, or if a person in
18 attendance upon such inquiry shall without reasonable cause refuse to be
19 sworn or to be examined or to answer a question or to produce a book or
20 paper when ordered so to do by the officer conducting such inquiry, or
21 if a person, partnership, corporation, company, trust or association
22 fails to perform any act required by this section to be performed, such
23 person shall be guilty of a misdemeanor and shall be subject to a civil
24 penalty as set forth in subsection (e) of this section.
25 (e) (1) If after an investigation authorized under this section the
26 superintendent determines that the increase in the price of the critical
27 prescription drug is unjustified, the superintendent may, after notice
28 and a hearing, levy a civil penalty not to exceed the greater of:
29 (A) five thousand dollars for each offense;
30 (B) a multiple of two times the aggregate damages attributable to the
31 offense; or
32 (C) a multiple of two times the aggregate economic gain attributable
33 to the offense.
34 (2) If any person, partnership, corporation, company, trust or associ-
35 ation, that fails to submit a written statement required by the super-
36 intendent under subsection (a) of this section or violates subsection
37 (d) of this section, the superintendent may, after notice and a hearing,
38 levy a civil penalty not to exceed to one thousand dollars per day that
39 such failure continues.
40 (f) For the purposes of this section, a "critical prescription drug"
41 shall be defined as one necessary to prevent or treat a disease or state
42 in which death is possible or imminent.
43 § 2. This act shall take effect immediately.
